【24h】

A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland

机译:波兰多药抗性结核流行病学与传播的特写镜头

获取原文
获取原文并翻译 | 示例
       

摘要

Multidrug-resistant tuberculosis (MDR-TB) poses a serious challenge to the global control of the disease. The purpose of this study was to characterize MDR-TB patients from Poland and to determine the extent of MDR-TB disease attributable to recent transmission. The study included all 46 patients diagnosed with MDR-TB in Poland in 2004 and followed up for 6 years (until 2011). For each patient, sociodemographic and clinical characteristics, treatment outcomes, and bacteriological data were collected by the review of medical and laboratory records. Mycobacterium tuberculosis isolates from all patients were characterized using spoligotyping, mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR) typing, IS6110 restriction fragment length polymorphism (RFLP) analysis, and sequencing analysis of drug resistance-associated loci (katG, mabA-inhA, rpo beta, rpsL, and embB). The majority of patients were male (86.9 %), 40-64 years of age (60.8 %), with a history of TB treatment (84.8 %), and producing smear-positive sputa (86.9 %). Twenty-two (47.8 %) patients suffered from concomitant diseases and 28 (60.8 %) were alcohol abusers. Treatment outcome assessment revealed that 8 (17.4 %) patients were cured or completed therapy, while 15 (32.6 %) died of TB, 11 (23.9 %) defaulted, 8 (17.4 %) failed, and 1 (2.2 %) was transferred and lost to follow-up. Upon genotyping, 10 (21.7 %) isolates were allocated in four clusters. These were further subdivided by mutational profiling. Overall, in 6 (13 %) patients, MDR-TB was a result of recent transmission. For 4 (8.7 %) of these patients, a direct epidemiological link was established. The study shows that the transmission of MDR-TB occurs at a low rate in Poland. Of urgent need is the implementation of a policy of enforced treatment of MDR-TB patients in Poland.
机译:多药结核(MDR-TB)对全球对疾病的控制构成了严峻挑战。本研究的目的是表征来自波兰的MDR-TB患者,并确定近期传播的MDR-TB疾病程度。该研究包括2004年在波兰诊断出MDR-TB的所有46名患者,并随访6年(直到2011年)。对于每位患者,通过审查医学和实验室记录,收集了社会阶段,社会阶乘和临床特征,治疗结果和细菌数据。所有患者的结核分枝杆菌分离株都使用尖锐型分类,分枝杆菌散射重复单元变量数串联重复(Miru-VNTR)键入,IS6110限制性片段长度多态性(RFLP)分析,以及药物抵抗相关基因座的测序分析(Katg,Maba -inha,RPO Beta,RPSL和emb)。大多数患者是男性(86.9%),40-64岁(60.8%),具有Tb治疗的历史(84.8%),产生涂片阳性痰(86.9%)。二十二(47.8%)患有伴随疾病的患者,28例(60.8%)是酒精滥用者。治疗结果评估显示,8例(17.4%)患者被固化或完成治疗,而15(32.6%)死于TB,11(23.9%)违约,8(17.4%)失败,1(2.2%)转移和失去了跟进。在基因分型后,将10(21.7%)分离物分配在四个簇中。这些通过突变分析进一步细分。总体而言,在6名(13%)患者中,MDR-TB是最近传播的结果。对于4名(8.7%)这些患者,建立了直接流行病学联系。该研究表明,MDR-TB的传输以低速率在波兰的低速下发生。迫切需要是实施强迫治疗波兰MDR-TB患者的政策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号